Girinimbine

CAS No. 23095-44-5

Girinimbine( —— )

Catalog No. M37784 CAS No. 23095-44-5

Girinimbine (Girinimbin) is a carbazole alkaloid isolated from the plants M. koenigii, M. koenigii, and Murraya koenigii.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 753 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Girinimbine
  • Note
    Research use only, not for human use.
  • Brief Description
    Girinimbine (Girinimbin) is a carbazole alkaloid isolated from the plants M. koenigii, M. koenigii, and Murraya koenigii.
  • Description
    Girinimbine (Girinimbin) is a carbazole alkaloid with a variety of biological effects. Girinimbine can induce apoptosis, and has antitrypanosomal, antiplatelet activity, antibacterial activity, anti-inflammatory, antioxidant and antitumor activities.
  • In Vitro
    Girinimbine (1-400 μM; 24-72 h) decreases the viability of HepG2 cells in 24, 48 and 72 h with IC50 values of 61 μM, 56 μM, and 40 μM respectively. Girinimbine (10-100 μM; 24-48 h) increase of LDH leakage in both concentration- and time-dependent manner in HepG2 cells.Girinimbine (56 μM; 24-48 h) treatment results in DNA fragmentation and elevates levels of caspase-3 in HepG2 cells.HepG2 cells.Girinimbine (56 μM; 12-48 h) treatment also displays a time-dependent accumulation of the Sub-G0/G1 peak (hypodiploid) and caused G0/G1-phase arrest.Girinimbine shows a potent antitrypanosomal activitywith an IC50 value of 10.16 μg/mL.Cell Viability Assay Cell Line:HepG2 cells Concentration:1 μM, 10 μM, 50 μM, 100 μM, 200 μM Incubation Time:24 h, 48 h and 72 h Result:Inhibited the proliferation of HepG2 cells in vitro in a dose- and time-dependent manner.Apoptosis Analysis Cell Line:HepG2 cells Concentration:56 μM Incubation Time:24 h, 48 h Result:Showed typical morphological features of apoptosis.Cell Cycle Analysis Cell Line:HepG2 cells Concentration:56 μM Incubation Time:12 h, 24 h, 48 h Result:Induced G0/G1-phase arrest in HepG2 cells.
  • In Vivo
    Girinimbine (10-100 mg/kg; orally gavage; once) pretreatment helps limit total leukocyte migration, and reduced pro-inflammatory cytokine (IL-1β, TNF-α) levels in the peritoneal fluid. In vivo in zebrafish embryos, Girinimbine (20 μg/mL; 24 hours) shows significant distribution of apoptotic cells in embryos.Animal Model:Male ICR mice (25-35 g) treated with carrageenan Dosage:10 mg/kg, 30 mg/kg, and 100 mg/kg Administration: Orally gavage; once Result:Helped limit total leukocyte migration, and reduced pro-inflammatory cytokine levels in the peritoneal fluid.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Antioxidant
  • Recptor
    Antioxidant | Apoptosis | Antibacterial
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    23095-44-5
  • Formula Weight
    263.33
  • Molecular Formula
    C18H17NO
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Cc1cc2c3ccccc3[nH]c2c2C=CC(C)(C)Oc12
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Suvitha Syam, et al. The growth suppressing effects of girinimbine on HepG2 involve induction of apoptosis and cell cycle arrest. Molecules. 2011 Aug 23;16(8):7155-70.?
molnova catalog
related products
  • Ganoderic acid D

    Ganoderic acid D is one of the major components in Ganoderma triterpenes.

  • LDL-IN-3

    LDL-IN-3 shows anti-atherosclerotic and antioxidant activities.

  • 4-Hydroxyquinoline

    4-Hydroxyquinoline is a hydroxylated quinoline derivative with antimicrobial activity.